caldonirimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for caldonirimab, covering 2023-05-26 to 2023-05-26. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer [Phase 2]